Ophthalmologist Moss Fenberg takes patient care seriously, managing details of intravenous medicine down to the last drop. So, when given the opportunity, he opened an outpatient medical infusion ...
Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
The first cellular therapy for type 1 diabetes was approved by the US Food and Drug Administration (FDA) on 28 June. The drug, called Lantidra, is an infusion of insulin-producing pancreatic cells ...
ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ...
Hosted on MSN
Diabetes milestone: In major breakthrough, stem cell infusion restores insulin production in type 1 patients
In a first-of-its-kind clinical trial, scientists from the University of Toronto have shown that a single infusion of zimislecel — an allogeneic stem cell-derived islet therapy — can restore natural ...
The "Syringe Pumps Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback